Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
- PMID: 36404633
- PMCID: PMC9762853
- DOI: 10.1080/21645515.2022.2149015
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Comment in
-
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Author's reply to correspondence.Hum Vaccin Immunother. 2023 Dec 31;19(1):2168947. doi: 10.1080/21645515.2023.2168947. Epub 2023 Jan 19. Hum Vaccin Immunother. 2023. PMID: 36655383 Free PMC article.
Comment on
-
Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Results from an active pharmacovigilance study in central Italy.Hum Vaccin Immunother. 2022 Nov 30;18(6):2126668. doi: 10.1080/21645515.2022.2126668. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315849 Free PMC article.
References
-
- Ripabelli G, Sammarco ML, D’Amico A, De Dona R, Iafigliola M, Parente A, Samprati N, Santagata A, Adesso C, Natale A, et al. Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: results from an active pharmacovigilance study in central Italy. Hum Vaccin Immunother. 2022. Oct 31;2126668. Online ahead of print. doi:10.1080/21645515.2022.2126668. - DOI - PMC - PubMed
-
- Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M. GNB3 c.825c>t polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022. Aug 29;13:932043. doi:10.3389/fgene.2022.932043. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical